Comparison of effectiveness of Liposomal Cisplatin combined with Paclitaxel versus Cisplatin combined with Paclitaxel in patients with adenocarcinoma and undifferentiated carcinoma of the lungs.
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2016
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Jul 2011 Additional primary endpoints added as reported by Australian New Zealand Clinical Trials Registry.
- 08 Jul 2011 New source added and integrated (ACTRN12610000046000, Australian New Zealand Clinical Trials Registry).
- 08 Jul 2011 Actual initiation date (Sep 2007) added as reported by Australian New Zealand Clinical Trials Registry.